(Stroke. 1997;28:2060-2066.)
© 1997 American Heart Association, Inc.
Articles |
Correlation Between Motor Impairment and Infarct Volume After Permanent and Transient Middle Cerebral Artery Occlusion in the Rat
From Neurosciences Research, SmithKline Beecham Pharmaceuticals, Harlow, Essex, United Kingdom.
Correspondence to Dr Derek C. Rogers, Neurosciences Research, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, United Kingdom. E-mail Derek_C_Rogers{at}sbphrd.com
Background and Purpose There have been a number of recent reports describing the relationship between ischemic damage and various behavioral and functional measures, although there have been few studies that have demonstrated a direct correlation between functional impairment and lesion volume. The purpose of the present study was to assess functional outcome by measurement of motor impairment and to determine whether this correlated to a range of infarct volumes induced by varying the duration of focal ischemic insult in the rat.
Methods Male Sprague-Dawley rats were subjected to 0, 30, 60, or 120 minutes or permanent middle cerebral artery (MCA) occlusion by the intraluminal filament technique. Motor impairment was assessed by the accelerating rota-rod and grid-walking tests, and the brains were perfusion-fixed for histological determination of infarct volume and brain swelling 24 hours after MCA occlusion.
Results Marked impairment in performance of both motor tests was recorded in the 60-minute, 120-minute, and the permanent MCA occlusion groups when compared with sham-operated rats. There were significant correlations between regional infarct volume, brain swelling, and all behavioral measurements (all r2>.5, P<.001).
Conclusions The rota-rod and grid-walking tests of motor performance provide quantitative, objective, and reproducible measures of functional impairment of rats following an ischemic insult. These impairments correlate directly with infarct volume and provide information integral to future studies evaluating the effects of potential neuroprotective agents.
Key Words: cerebral ischemia, focal • reperfusion • motor activity • rat
This article has been cited by other articles:
 |
|
 |
|
  A. B. Salmon, V. I. Perez, A. Bokov, A. Jernigan, G. Kim, H. Zhao, R. L. Levine, and A. Richardson Lack of methionine sulfoxide reductase A in mice increases sensitivity to oxidative stress but does not diminish life span FASEB J, October 1, 2009; 23(10): 3601 - 3608. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L Gibson, B. Coomber, and J. Rathbone Is Progesterone a Candidate Neuroprotective Factor for Treatment following Ischemic Stroke? Neuroscientist, August 1, 2009; 15(4): 324 - 332. [Abstract] [PDF]
|
|
|
|
 |
|
 Y. Nonaka, A. Koumura, K. Hyakkoku, M. Shimazawa, S. Yoshimura, T. Iwama, and H. Hara Combination Treatment with Normobaric Hyperoxia and Cilostazol Protects Mice against Focal Cerebral Ischemia-Induced Neuronal Damage Better Than Each Treatment Alone J. Pharmacol. Exp. Ther., July 1, 2009; 330(1): 13 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Oyamada, M. Sone, K. Miyashita, K. Park, D. Taura, M. Inuzuka, T. Sonoyama, H. Tsujimoto, Y. Fukunaga, N. Tamura, et al. The Role of Mineralocorticoid Receptor Expression in Brain Remodeling after Cerebral Ischemia Endocrinology, August 1, 2008; 149(8): 3764 - 3777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Gibson, L. J. Gray, P. M. W. Bath, and S. P. Murphy Progesterone for the treatment of experimental brain injury; a systematic review Brain, February 1, 2008; 131(2): 318 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Kim, M. Rowe, M. Ren, J.-S. Hong, P.-S. Chen, and D.-M. Chuang Histone Deacetylase Inhibitors Exhibit Anti-Inflammatory and Neuroprotective Effects in a Rat Permanent Ischemic Model of Stroke: Multiple Mechanisms of Action J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 892 - 901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Inoue, D. P. Davis, J. C. Drummond, D. J. Cole, and P. M. Patel The combination of isoflurane and caspase 8 inhibition results in sustained neuroprotection in rats subject to focal cerebral ischemia. Anesth. Analg., May 1, 2006; 102(5): 1548 - 1555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K Shukla, V. K Khanna, M M. Ali, R. Maurya, M Y Khan, and R. C Srimal Neuroprotective effect of Acorus calamus against middle cerebral artery occlusion-induced ischaemia in rat Human and Experimental Toxicology, April 1, 2006; 25(4): 187 - 194. [Abstract] [PDF]
|
|
|
|
 |
|
 M. D. Lindner, V. K. Gribkoff, N. A. Donlan, and T. A. Jones Long-Lasting Functional Disabilities in Middle-Aged Rats with Small Cerebral Infarcts J. Neurosci., November 26, 2003; 23(34): 10913 - 10922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R. Crafton, A. N. Mark, and S. C. Cramer Improved understanding of cortical injury by incorporating measures of functional anatomy Brain, July 1, 2003; 126(7): 1650 - 1659. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ishibashi, T. Kuroiwa, S. Endo, R. Okeda, and H. Mizusawa Neurological Dysfunctions Versus Regional Infarction Volume After Focal Ischemia in Mongolian Gerbils Stroke, June 1, 2003; 34(6): 1501 - 1506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. C. Barone, E. A. Irving, A. M. Ray, J. C. Lee, S. Kassis, S. Kumar, A. M. Badger, R. F. White, M. J. McVey, J. J. Legos, et al. SB 239063, a Second-Generation p38 Mitogen-Activated Protein Kinase Inhibitor, Reduces Brain Injury and Neurological Deficits in Cerebral Focal Ischemia J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 312 - 321. [Abstract] [Full Text]
|
|
|
|
|
|
K. Hattori, H. Lee, P. D. Hurn, B. J. Crain, R. J. Traystman, A. C. DeVries, and B. G. Lyeth Cognitive Deficits After Focal Cerebral Ischemia in Mice Editorial Comment Stroke, August 1, 2000; 31(8): 1939 - 1944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Callaway, M. J. Knight, D. J. Watkins, P. M. Beart, B. Jarrott, and J. A. Clemens Delayed Treatment With AM-36, a Novel Neuroprotective Agent, Reduces Neuronal Damage After Endothelin-1-Induced Middle Cerebral Artery Occlusion in Conscious Rats • Editorial Comment Stroke, December 1, 1999; 30(12): 2704 - 2712. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Zhang, Z. G. Zhang, and M. Chopp Increased therapeutic efficacy with rt-PA and anti-CD18 antibody treatment of stroke in the rat Neurology, January 1, 1999; 52(2): 273 - 273. [Abstract] [Full Text]
|
|